Bryan Gilburg - China

“The TFDA will now require license holders submit installation records on an annual basis through their online portal.”

Bryan Gilburg

Managing Director, Asia Actual

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Sign Up For Our Newsletter to Stay Informed

Sign Up

TFDA Implements New Annual Reporting Requirements in Thailand

Published on: April 8th, 2022

Updated on: May 6th, 2022

On June 1, 2022, the Thai FDA released Gazette 138, Section 118 requiring license holders submit annual reports by March 31st of every year covering installations of products under the licenses they hold. Originally, all license holders were supposed to upload the reports by the end of March but due to issues with the e-portal, the TFDA is requesting hard copies as soon as possible and online submissions completed by September 30, 2022. The reports must include the date of sale/installation, name of the product, license number, manufacturing information, customer information, quantity, and value of purchase.

According to the new regulations, products registered under new rules (apply to applications submitted after February 15, 2021) that were imported/sold in the previous year must be reported to the TFDA by March 31, 2022. License holders could be prosecuted and fined for not submitting reports in time. Manufacturers can determine if their product is registered under the old or new rules by the format of their registration number. If it’s 65-2-2-2-0002736, then the product was registered under the new rules whereas if the license number has a 3 letter country abbreviation followed by 8 numbers (i.e. FRA 7311311) was registered under the old rules.

The original post can be found here and a Google translated version can be found here.

Additional Notes

The TFDA has not ruled out that there will be exceptions to this rule and will entertain questions from manufacturers on whether their products need to be reported in this format. For example, there may be some medical devices like software that do not collect installation records of every customer and may not be able to be able to feasibly report this information.

Regarding the values the TFDA will expect to see, the Import Value is the Import Entry Declaration (THB) while the Value of Sale can include all amounts except for VAT.

For more information on registering your medical device in Thailand, please see our page on the topic here.

Come Grow with Us

Contact Asia Actual if you’d like to learn how this regulation might affect your products in Thailand.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

Japan's Innovative Medical Device Regulatory Pathway is called Sakigake

Innovative Medical Device Registration in Japan

In 2019, Japan's Ministry of Health, Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) introduced a innovative device registration designation system, called Sakigake, which is meant to streamline the regulatory pathway for qualifying medical products.
PMDA Representative consulting with medical device manufacturers in Japan

Medical Device Consultation in Japan

Medical device consultation in Japan is a very involved but essential process in registering a medical device. A significant part of the regulatory process in Japan is consultation meetings with the Pharmaceuticals and Medical Devices Agency (PMDA).
Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.